Position in NVS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$15,672
+$397 QoQ
Shares Held
100
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,506
of 1,603 holders
Holding Since
Mar 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Strengthening Families & Communities, LLC holds $15,119,704 across 12 Drug Manufacturers - General names. NVS ranks #8 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
21,481 | $5,455,529 | |
| 2 | MRK |
Merck & Co., Inc.
|
41,350 | $5,313,475 | |
| 3 | LLY |
ELI LILLY & Co
|
3,421 | $4,103,250 | |
| 4 | AZN |
Astrazeneca PLC
|
506 | $95,947 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
427 | $53,947 | |
| 6 | ABBV |
AbbVie Inc.
|
176 | $44,288 | |
| 7 | AMGN |
Amgen Inc
|
75 | $27,159 | |
| 8 | NVS |
Novartis AG
This page
|
100 | $15,672 |
All Filings in NVS
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,672 | 100 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $15,275 | 100 | Shares | Sole | 2026-05-11 | |
| 2025-09-30 | $18,979 | 148 | Shares | Sole | 2025-11-04 | |
| 2025-03-31 | $16,499 | 148 | Shares | Sole | 2025-05-12 | |
| 2024-09-30 | $28,755 | 250 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $26,614 | 250 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $23,989 | 248 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $10,097 | 100 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $10,186 | 100 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $10,091 | 100 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $9,200 | 100 | Shares | Sole | 2023-05-04 | |
| No filing history on record for this holder in this stock. | ||||||